Envoy Medical COCH Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.
The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's deferred tax assets, valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's deferred tax assets, valuation allowance?
- Envoy Medical (COCH) reported deferred tax assets, valuation allowance of $50.16M in Q4 2025.
- What is the long-term trend for Envoy Medical's deferred tax assets, valuation allowance?
- Over 3 years (2022 to 2025), Envoy Medical's deferred tax assets, valuation allowance has grown at a 326.8% compound annual growth rate (CAGR), from $645K to $50.16M.